Leuprorelin implant - AMW
Alternative Names: Leugon; StaladexLatest Information Update: 29 May 2024
At a glance
- Originator AMW GmbH
- Class Antineoplastics; Gonadotropins; Infertility therapies; Oligopeptides; Pituitary hormone releasing hormones
- Mechanism of Action Gonadotropin releasing hormone stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Prostate cancer
Most Recent Events
- 12 Feb 2010 Phase-III clinical trials in Prostate cancer in Germany (SC)